Aromatase inhibitors therapy and major osteoporotic fracture risk in postmenopausal breast cancer patients: a nationwide real-world cohort study

Abstract Background The increased risk of fractures associated with aromatase inhibitors (AIs) therapy has been well established in clinical trials; however, data on Asian populations remain limited. Furthermore, the impact of AIs on fracture risk across different age groups and breast cancer stages...

Full description

Saved in:
Bibliographic Details
Main Authors: Pin-Han Liu, Ching-Fang Tsai, Yu-Chen Hsu, Cheng-Yi Wu, Hsin-Yi Yang
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Breast Cancer Research
Subjects:
Online Access:https://doi.org/10.1186/s13058-025-02050-5
Tags: Add Tag
No Tags, Be the first to tag this record!